Ferring statement on subsidised pricing of heat-stable carbetocin for the prevention of postpartum haemorrhage in low- and lower-middle income countries
Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments
Ferring International Center S.A.Ch. de la Vergognausaz 50CH-1162 Saint-PrexSwitzerlandTel: +41 58 301 00 00Fax: +41 58 301 00 10
Email for media enquiries only.For other queries, please see our Contact page.
FERRING INTERNATIONAL CENTER S.A.CH. DE LA VERGOGNAUSAZ 50 1162 SAINT-PREXSWITZERLAND
TEL: +41 58 301 00 00FAX: +41 58 301 00 10
This global corporate website provides general information about the global Ferring Group. For information about Ferring or its products in a specific country, please select your country in the Global Locator. FERRING, the FERRING PHARMACEUTICALS logo and other Ferring product trade names are trademarks of Ferring B.V. save where indicated otherwise. ©2018 Ferring B.V.